3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Recruiting
2
Completed
2
Sponsor Class
OTHER
44
OTHER_GOV
2
NIH
1
NETWORK
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Gemcitabine
15
Cisplatin
12
Radiotherapy
11
Metformin
8
Fluorouracil
8
Capecitabine
8
Paclitaxel
7
Oxaliplatin
7
Exercise
7
Indocyanine Green
6
Docetaxel
6
Cyclophosphamide
6
Control Groups
6
Surveys and Questionnaires
5
Standard of Care
5
Nivolumab
5
Letrozole
5
Irinotecan
5
pembrolizumab
4
durvalumab
4
Zoledronic Acid
4
Vinorelbine
4
Saline Solution
4
Preoperative Exercise
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Ifosfamide
4
Gefitinib
4
Drug Therapy
4
Carboplatin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
OTHER_GOV
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT02258165
2023-04-18
IMAGE
Queensland Centre for Gynaecological Cancer
Completed
84 enrolled
NCT02002455
2016-10-21
Flucipro
Turku University Hospital
Phase 2
Completed
26 enrolled